The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma

BACKGROUND: Hepatitis C virus (HCV)-infected patients with hepatocellular carcinoma (HCC) are at high risk for direct-acting antiviral (DAA) failure and controversy exists on the increased risk of HCC recurrence following DAAs. Herein, we evaluate the efficacy, safety and oncologic outcomes of HCV-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Economides, Minas, Hosry, Jeff, Angelidakis, Georgios, Kaseb, Ahmed, Torres, Harrys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632169/
http://dx.doi.org/10.1093/ofid/ofx163.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632169/
http://dx.doi.org/10.1093/ofid/ofx163.390

Ejemplares similares